Bionomics Ltd.
October 10, 2023 - by Joey Ramson
$BNOX popped a few weeks ago after a positive update on their Phase 2b trial for PTSD. The drug, called BNC210 as of now, not only reached its primary endpoint for PTSD but secondary endpoints for depression and insomnia as well. It looks like as long as it can hold and not close below about $2.50, the bottom of the red support zone, $BNOX can go up further.
